Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer
Open Access
- 1 February 1999
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (2) , 309-318
- https://doi.org/10.1016/s0149-2918(00)88288-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Recent Trends in U.S. Breast Cancer Incidence, Survival, and Mortality RatesJNCI Journal of the National Cancer Institute, 1996
- Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodiesCancer Immunology, Immunotherapy, 1993
- Breast CancerNew England Journal of Medicine, 1992
- Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth.Proceedings of the National Academy of Sciences, 1991
- Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.Proceedings of the National Academy of Sciences, 1989
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431.Proceedings of the National Academy of Sciences, 1978